General Rheumatology

Human Trial of Antibody Therapy to Treat COVID-19 Underway

The first human trial of an antibody therapy to treat COVID-19 is underway.

SMS Resources Beneficial to Patients With Rheumatic Diseases During the COVID-19 Pandemic

SMS-embedded video links may be a potential tool for rheumatology departments to contact patients during and after the COVID-19 pandemic.

Veterans Administration Stops Nearly All Use of Hydroxychloroquine to Treat COVID-19

The VA health system has stopped nearly all use of hydroxychloroquine to treat COVID-19 patients.

Large Study Finds No Benefit of Hydroxychloroquine or Chloroquine for COVID-19

Use of hydroxychloroquine or chloroquine may increase the risk of ventricular arrhythmia and death in patients hospitalized.

Tooth Loss More Prevalent in Adults With Chronic Disease

Adults with severe chronic disease or with fair or poor general health have a higher prevalence of edentulism and severe tooth loss.

Genetic Data May Increase Diagnostic Efficiency for Rheumatic Disease

Converting genotype information into an interpretable probability value for five different inflammatory arthritis-causing diseases could potentially improve the diagnostic efficiency of rheumatic disease.

The Autoimmune COVID-19 Project: A Patient-Centered Initiative

Study leads Shilpa Venkatachalam, MD, and Michael George, MD, discuss the highlights of a new initiative to track the effects of COVID-19 in autoimmune disorders.

Considerations for Hydroxychloroquine Use in Patients With Diabetes

Careful consideration should be taken before using hydroxychloroquine in patients with diabetes, particularly in the context of COVID-19.

WHO Suspends Testing of Hydroxychloroquine in Patients With COVID-19

The WHO has suspended use of the antimalarial drug hydroxychloroquine in a clinical trial of treatments of COVID-19 after a study revealed that patients taking the drug are at increased risk for death and serious heart problems.

Intravenous Anakinra May Be Useful in the Treatment of Cytokine Storm Syndromes

Authors of this viewpoint described the current challenges in the management of cytokine storm syndromes and reviewed the safety profile of intravenous anakinra.

CDC: COVID-19 Does Not Spread Easily From Contaminated Surfaces

COVID-19 spreads swiftly between people but is not easily caught from contaminated surfaces, according to updated information from the CDC.

EULAR Recommendations for the Management of Rheumatic Immune-Related Adverse Events Due to Cancer Immunotherapy

A EULAR task force developed recommendations for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy.

Managing Sarcoidosis During the COVID-19 Pandemic: An Expert Guidance Statement

In patients with sarcoidosis, COVID-19 can increase the risk for poor outcomes and death, which has resulted in the need for additional guidance on caring for these patients during the pandemic.

NIH: Large-Scale Testing of COVID-19 Vaccines Could Begin in July

A number of COVID-19 vaccines under development “look pretty promising” and one or two could be ready for large-scale testing by July.

Hydroxychloroquine Does Not Improve COVID-19 Pneumonia Outcomes

Hydroxychloroquine does not improve outcomes in COVID-19.